Because ANP32A expression was associated with lymph node metastasis and tumor differentiation, we further evaluated the joint effect of ANP32A expression and the two pathological factors on mortality. This evidence concerns the gene ANP32A and metastatic malignant neoplasm in the lymph nodes.